NO20080800L - Kimaere antistoffer med New World primat regioner - Google Patents

Kimaere antistoffer med New World primat regioner

Info

Publication number
NO20080800L
NO20080800L NO20080800A NO20080800A NO20080800L NO 20080800 L NO20080800 L NO 20080800L NO 20080800 A NO20080800 A NO 20080800A NO 20080800 A NO20080800 A NO 20080800A NO 20080800 L NO20080800 L NO 20080800L
Authority
NO
Norway
Prior art keywords
regions
new world
chimeric antibodies
world primate
cdr
Prior art date
Application number
NO20080800A
Other languages
English (en)
Inventor
Philip Anthony Jennings
Anthony Gerard Doyle
Adam William Clarke
Original Assignee
Arana Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2005904406A external-priority patent/AU2005904406A0/en
Application filed by Arana Therapeutics Ltd filed Critical Arana Therapeutics Ltd
Publication of NO20080800L publication Critical patent/NO20080800L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

SAMMENDRAG Foreliggende oppfinnelse tilveiebringer et kimærisk antistoff eller en antigenbindende del derav. Den antigenbindende delen omfatter minst to komplementaritetsbestemmende regioner (CDR) og minst tre rammeverkregioner, der minst én CDR er en CDR fra den nye verdens primater.
NO20080800A 2005-08-15 2008-02-14 Kimaere antistoffer med New World primat regioner NO20080800L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2005904406A AU2005904406A0 (en) 2005-08-15 New World Antibodies
PCT/AU2006/001166 WO2007019621A1 (en) 2005-08-15 2006-08-15 Chimeric antibodies with new world primate regions

Publications (1)

Publication Number Publication Date
NO20080800L true NO20080800L (no) 2008-05-09

Family

ID=37757238

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080800A NO20080800L (no) 2005-08-15 2008-02-14 Kimaere antistoffer med New World primat regioner

Country Status (13)

Country Link
EP (1) EP1945669A4 (no)
JP (1) JP2009504686A (no)
KR (1) KR20080068005A (no)
CN (2) CN101287762A (no)
AU (1) AU2006281981A1 (no)
BR (2) BRPI0614430A2 (no)
CA (1) CA2619245A1 (no)
MX (1) MX2008002161A (no)
NO (1) NO20080800L (no)
NZ (1) NZ565904A (no)
RU (1) RU2008110058A (no)
WO (1) WO2007019621A1 (no)
ZA (2) ZA200802247B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA014226B1 (ru) 2004-07-26 2010-10-29 Байоджен Айдек Ма Инк. Антитела к cd154, их фрагменты и способы применения антител и фрагментов
CN101400703B (zh) 2006-02-01 2013-05-08 赛法隆澳大利亚控股有限公司 结构域抗体构建体
PT2125894T (pt) * 2007-03-22 2019-02-27 Biogen Ma Inc Proteínas de ligação incluindo anticorpos, derivados de anticorpos e fragmentos de anticorpos que se ligam especificamente ao cd154 e as suas utilizações
CA2733742A1 (en) * 2008-08-14 2010-02-18 Cephalon Australia Pty Ltd Variant domain antibodies
RU2505312C2 (ru) * 2010-08-06 2014-01-27 Олег Ильич Эпштейн Комплексное лекарственное средство для лечения гриппа различных типов
RU2577299C2 (ru) * 2011-07-04 2016-03-10 Олег Ильич Эпштейн Способ лечения инфекционных заболеваний и комплексное лекарственное средство для лечения инфекционных заболеваний
RU2517085C2 (ru) * 2010-08-06 2014-05-27 Олег Ильич Эпштейн Комплексное лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
RU2516931C2 (ru) * 2010-08-06 2014-05-20 Олег Ильич Эпштейн Способ и композиция для профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
RU2535034C2 (ru) * 2010-08-06 2014-12-10 Олег Ильич Эпштейн Лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
RU2519862C2 (ru) * 2010-08-06 2014-06-20 Олег Ильич Эпштейн Комплексное лекарственное средство и способ профилактики и лечения инфекционных вирусных заболеваний
RU2521392C2 (ru) * 2010-08-06 2014-06-27 Олег Ильич Эпштейн Комплексное лекарственное средство для лечения вирусных заболеваний и способ лечения вирусных заболеваний
RU2535033C2 (ru) * 2010-08-06 2014-12-10 Олег Ильич Эпштейн Лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
RU2502521C2 (ru) * 2010-08-06 2013-12-27 Олег Ильич Эпштейн Комплексное лекарственное средство для лечения бактериальных инфекций и способ лечения бактериальных инфекций
RU2579262C1 (ru) * 2014-10-02 2016-04-10 Мапикс Эс.Эй.Ар.Эл. Лекарственное средство для лечения инфекционных заболеваний
CL2015002152A1 (es) * 2015-07-31 2016-06-03 Pontificia Universidad Católica De Chile Anticuerpos monoclonales específicos para el antígeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnostico de la infección causada por vrsh
CN120366228A (zh) * 2025-04-24 2025-07-25 梅州市人民医院(梅州市医学科学院) 一种分泌钙调宁蛋白2单克隆抗体的杂交瘤细胞株2f8、单克隆抗体及制备和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2114015C (en) * 1991-07-25 2002-12-10 Roland A. Newman Recombinant antibodies for human therapy
US6569431B2 (en) * 2000-10-17 2003-05-27 The Regents Of The University Of California Recombinant antibody fragments as autoantibody antagonists
US7235643B2 (en) * 2000-11-07 2007-06-26 Morphotek, Inc. Antibodies and methods for generating genetically altered antibodies with high affinity
ES2263984T3 (es) * 2002-06-28 2006-12-16 Domantis Limited Ligandos doble-especificos con una vida media serica aumentada.
CA2543631A1 (en) * 2003-11-07 2005-05-26 Amgen Inc. Monkey immunoglobulin sequences

Also Published As

Publication number Publication date
MX2008002161A (es) 2008-04-22
JP2009504686A (ja) 2009-02-05
AU2006281981A1 (en) 2007-02-22
WO2007019621A1 (en) 2007-02-22
BRPI0614430A2 (pt) 2011-03-29
CN101287762A (zh) 2008-10-15
ZA200802246B (en) 2009-09-30
CN101287763A (zh) 2008-10-15
RU2008110058A (ru) 2009-09-27
ZA200802247B (en) 2009-08-26
KR20080068005A (ko) 2008-07-22
BRPI0614867A2 (pt) 2012-01-31
EP1945669A1 (en) 2008-07-23
NZ565904A (en) 2012-02-24
CA2619245A1 (en) 2007-02-22
EP1945669A4 (en) 2009-07-22

Similar Documents

Publication Publication Date Title
NO20080800L (no) Kimaere antistoffer med New World primat regioner
NO20080799L (no) Omkonstruerte antistoffer med New World primate rammeverksregioner
MX379660B (es) Anticuerpo anti-receptor de linfocitos t alfa-beta.
CR20110577A (es) Proteínas de unión a il-1
DK1716181T3 (da) CDR-reparerede antistoffer
CR8958A (es) Anticuerpos Anti-5T4 humanizados y conjugados de anticuerpos anti-5T4/caliqueamicina
NO20074867L (no) Antistoffer mot CCR5 og anvendelser derav
DK2070948T3 (da) Humant Anti-CD4-antistof med immunsuppressive egenskaber
WO2008006235A3 (en) Scfv antibodies which pass epithelial and/or endothelial layers
CO6781489A2 (es) Proteínas de unión al tnf-α
NZ703035A (en) Anti-human respiratory syncytial virus (rsv) antibodies and methods of use
PE20141398A1 (es) Anticuerpos neutralizantes de citomegalovirus humano
NO20091411L (no) Interleukin-13-bindende proteiner
WO2013054331A8 (en) Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam)
NO20066052L (no) Anti-CD3 antistoffer og fremgangsmater for anvendelse derav
NZ611269A (en) Neutralizing anti-ccl20 antibodies
RU2531523C3 (ru) Стабильные и растворимые антитела, ингибирующие vegf
PE20110801A1 (es) Anticuerpos con reactividad cruzada y biespecificos anti-il-17a/f
MX2010007935A (es) Anticuerpo monoclonal humanizado anti-nkg2a humano.
NZ602676A (en) Anti-vla-4 antibodies
NZ600915A (en) Humanised antibodies with anti-tumour activity
WO2012170929A3 (en) Monoclonal antibody and antigens for diagnosing and treating lung disease and injury
AR117548A1 (es) Anticuerpos monoclonales específicos para la proteína quimérica l del virus de la parainfluenza humana (piv), secuencias nucleotídicas; método y kit de diagnóstico de infección producida por piv
MX2024010796A (es) Anticuerpos anti-cd73 y uso de los mismos.
UA98100C2 (ru) Гуманизированное моноклональное антитело, которое связывается с человеческим nogo и нейтрализует его

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application